文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

DNA Sequencing in Adults With Acute Myeloid Leukemia to Detect Residual Disease Prior to Hematopoietic Cell Transplant.

作者信息

Khaire Niranjan Shiwaji, Kim Dennis Dong Hwan, Law Arjun D

机构信息

Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

出版信息

JAMA. 2023 Jul 11;330(2):190. doi: 10.1001/jama.2023.8650.

DOI:10.1001/jama.2023.8650
PMID:37432435
Abstract
摘要

相似文献

[1]
DNA Sequencing in Adults With Acute Myeloid Leukemia to Detect Residual Disease Prior to Hematopoietic Cell Transplant.

JAMA. 2023-7-11

[2]
DNA Sequencing in Adults With Acute Myeloid Leukemia to Detect Residual Disease Prior to Hematopoietic Cell Transplant-Reply.

JAMA. 2023-7-11

[3]
Minimal residual disease-directed therapy in acute myeloid leukemia.

Blood. 2015-4-9

[4]
The impact of minimal residual disease prior to unmanipulated haploidentical hematopoietic stem cell transplantation in patients with acute myeloid leukemia in complete remission.

Leuk Lymphoma. 2017-5

[5]
The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia.

Blood Cancer J. 2021-4-1

[6]
Next-generation sequencing-defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse.

Am J Hematol. 2019-6-14

[7]
Minimal residual disease diagnostics and chimerism in the post-transplant period in acute myeloid leukemia.

ScientificWorldJournal. 2011-2-3

[8]
Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing.

PLoS One. 2019-10-28

[9]
Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia.

Haematologica. 2017-1

[10]
Monitoring of post-transplant CBFB-MYH11 as minimal residual disease, rather than KIT mutations, can predict relapse after allogeneic haematopoietic cell transplantation in adults with inv(16) acute myeloid leukaemia.

Br J Haematol. 2018-2

引用本文的文献

[1]
Quantification of the FLT3 internal tandem duplication is a reliable marker for monitoring measurable residual disease in acute myeloid leukemia with FLT3-ITD mutations.

Bone Marrow Transplant. 2025-3

[2]
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia.

Bone Marrow Transplant. 2025-2

[3]
Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study.

Blood Cancer J. 2024-6-13

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索